Olanzapine long-acting injectable (LAI) suspension (TEV-'749) has the potential to offer the efficacy of olanzapine in a once-monthly, subcutaneous formulation1If approved, TEV-'749 could help address ...

MDC recommends exemption of first indigenously developed antibiotic nafithromycin from DPCO: Gireesh Babu, New Delhi Friday, February 20, 2026, 08:00 Hrs [IST] The Multidisciplina ...

New delivery system targets rapid-onset relief for motion sickness and vertigo, modernizing the $450M global market for the ...

CD Bioparticles launches comprehensive OMV-Based Bacterial Vaccines Development services for infectious disease and ...

XI'AN CITY, SHAANXI PROVINCE, CHINA, February 5, 2026 /EINPresswire.com/ -- The nutritional supplement industry is ...

India’s drug regulator has ordered updated safety warnings for doxycycline and carbimazole after reviews flagged new adverse effects, aiming to better inform doctors and patients.

Wall Street analysts are placing aggressive bets on four clinical-stage biotech companies, with consensus price targets implying gains of up to 384%. These pre-revenue or early-revenue firms carry ...

Ocular Therapeutix reported a phase 3 win that it believes can validate its attempts to challenge Regeneron’s entrenched ...

Canada's health regulator has approved Merck's new under-the-skin version of its cancer drug Keytruda, offering an alternative to the current intravenous infusion. Health Canada has approved Keytruda ...

After the weight-loss drug boom, and with generics closing in, Big Pharma are gearing up for the next game-changer.

NRx together with Osmind, Inc. conducted an in-person meeting attended by leadership of the FDA Division of Psychiatry ...

Ahmedabad: Zydus Lifesciences Limited has secured final approval from the United States Food and Drug Administration (USFDA) for Bosentan tablets for oral suspension, 32 mg, further ...